We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+10.55%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.9B
AUM Growth
+$82.9M
(+0.56%)
Cap. Flow
-$1.22B
Cap. Flow
% of AUM
-8.19%
Top 10 Holdings %
Top 10 Hldgs %
17.88%
Holding
1,150
New
131
Increased
316
Reduced
491
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$108M |
| 2 |
AT&T
T
|
+$102M |
| 3 |
Valero Energy
VLO
|
+$70.6M |
| 4 |
Marathon Petroleum
MPC
|
+$53.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$51.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.1M |
| 2 |
Dell
DELL
|
+$87.8M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$85.7M |
| 4 |
General Motors
GM
|
+$85.2M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Healthcare | 14.02% |
| 3 | Consumer Discretionary | 12.92% |
| 4 | Financials | 11.35% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Theravance Biopharma
TBPH
$875M
| $11.3M | 0.08% |
1,022,928
+377,051
| +58% | +$3.29M |
|
|
TVRD
277
Tvardi Therapeutics
TVRD
$22.9M
| $11.3M | 0.08% |
25,708
+960
| +4% | +$482K |
|
|
GBT
278
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11.2M | 0.08% |
384,168
+86,117
| +29% | +$2.67M |
|
279
DexCom
DXCM
$28.9B
| $11.2M | 0.08% |
+83,620
| New | +$12M |
|
|
PDM
280
Piedmont Realty Trust
PDM
$1.2B
| $11.2M | 0.07% |
607,759
+81,242
| +15% | +$1.49M |
|
281
Green Dot
GDOT
$758M
| $11.2M | 0.07% |
308,232
-204,076
| -40% | -$8.34M |
|
|
ESGR
282
DELISTED
Enstar Group
ESGR
| $11.1M | 0.07% |
44,803
-13,709
| -23% | -$3.25M |
|
|
SIX
283
DELISTED
Six Flags Entertainment Corp.
SIX
| $10.9M | 0.07% |
256,893
+217,186
| +547% | +$9.05M |
|
284
Tenet Healthcare
THC
$22.6B
| $10.9M | 0.07% |
133,557
-22,356
| -14% | -$1.63M |
|
285
Cummins
CMI
$88.5B
| $10.9M | 0.07% |
49,962
+30,992
| +163% | +$7.06M |
|
286
Arlo Technologies
ARLO
$1.55B
| $10.9M | 0.07% |
1,035,785
+9,158
| +0.9% | +$71.5K |
|
287
Seres Therapeutics
MCRB
$46.5M
| $10.7M | 0.07% |
+64,515
| New | +$10.3M |
|
288
Unisys
UIS
$250M
| $10.7M | 0.07% |
520,606
-110,253
| -17% | -$2.42M |
|
|
NVRO
289
DELISTED
NEVRO CORP.
NVRO
| $10.7M | 0.07% |
131,640
+119,456
| +980% | +$12M |
|
290
OFG Bancorp
OFG
$2.24B
| $10.7M | 0.07% |
401,598
-18,877
| -4% | -$489K |
|
291
Usana Health Sciences
USNA
$429M
| $10.7M | 0.07% |
105,297
+61,154
| +139% | +$6.1M |
|
292
Lumen
LUMN
$6.38B
| $10.6M | 0.07% |
844,265
-839,899
| -50% | -$10.7M |
|
293
Compass Minerals
CMP
$1.25B
| $10.6M | 0.07% |
+206,566
| New | +$12.6M |
|
|
MCHB
294
Mechanics Bancorp
MCHB
$3.51B
| $10.5M | 0.07% |
201,624
-20,718
| -9% | -$998K |
|
295
Perdoceo Education
PRDO
$2.06B
| $10.4M | 0.07% |
886,343
+130,458
| +17% | +$1.42M |
|
296
Airbnb
ABNB
$90.9B
| $10.4M | 0.07% |
62,456
+3,046
| +5% | +$536K |
|
297
Synaptics
SYNA
$4.33B
| $10.4M | 0.07% |
35,814
-238,040
| -87% | -$56.9M |
|
298
Gossamer Bio
GOSS
$100M
| $10.3M | 0.07% |
908,432
-68,931
| -7% | -$819K |
|
299
Assurant
AIZ
$14B
| $10.2M | 0.07% |
65,523
+32,363
| +98% | +$5.13M |
|
300
UMB Financial
UMBF
$10.9B
| $10.2M | 0.07% |
96,145
-444
| -0.5% | -$45.8K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2021 Portfolio in Review
As of Q4 2021, Jacobs Levy Equity Management held 1,150 positions worth $14.9B, up 0.56% from $14.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management withdrew a net $1.22B in Q4 2021, closing 190 positions and reducing 491 holdings. Its most notable exit was Cerner Corp, an estimated $46M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jacobs Levy Equity Management opened a new position in Booking.com worth $109M.
- Jacobs Levy Equity Management's largest Q4 2021 buy was Booking.com: 1,135,900 shares worth $109M.
- Jacobs Levy Equity Management added most to AT&T in Q4 2021, an estimated $102M increase.
- Jacobs Levy Equity Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $89.1M.
- Jacobs Levy Equity Management fully exited Cerner Corp in Q4 2021, selling an estimated $46M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $14.9B portfolio in Q4 2021.
- Jacobs Levy Equity Management opened 131 new positions and closed 190 in Q4 2021.
- Jacobs Levy Equity Management's portfolio value rose 0.56% quarter-over-quarter to $14.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.